CG
IOVA icon

Cutler Group’s Iovance Biotherapeutics IOVA Stock Holding History

Cutler Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6K Buy
+21,200
New +$247K ﹤0.01% 1502
2023
Q4 		– Sell
-3,500
Closed -$10K – 3950
2023
Q3 		$10K Buy
+3,500
New +$22.9K ﹤0.01% 2473
2022
Q4 		– Sell
-600
Closed -$1K – 4787
2022
Q3 		$1K Sell
600
-500
-45% -$5.77K ﹤0.01% 4572
2022
Q2 		$2K Sell
1,100
-23,600
-96% -$309K ﹤0.01% 4293
2022
Q1 		$13K Buy
24,700
+20,400
+474% +$315K ﹤0.01% 3392
2021
Q4 		$12K Sell
4,300
-52,100
-92% -$1.15M ﹤0.01% 3538
2021
Q3 		$97K Buy
56,400
+39,700
+238% +$935K ﹤0.01% 1945
2021
Q2 		$18K Buy
16,700
+16,100
+2,683% +$418K ﹤0.01% 3390
2021
Q1 		$1K Buy
+600
New +$24.9K ﹤0.01% 5251
2020
Q4 		– Sell
-1,100
Closed -$4K – 5126
2020
Q3 		$4K Sell
1,100
-4,700
-81% -$144K ﹤0.01% 3659
2020
Q2 		$9K Buy
5,800
+2,500
+76% +$82.2K ﹤0.01% 2947
2020
Q1 		$16K Buy
+3,300
New +$87.5K ﹤0.01% 2446
2018
Q1 		– Sell
-1,900
Closed -$3K – 4810
2017
Q4 		$3K Buy
+1,900
New +$15.3K ﹤0.01% 3957
2017
Q3 		– Sell
-6,500
Closed -$8K – 6233
2017
Q2 		$8K Buy
+6,500
New +$41.3K ﹤0.01% 4370
2017
Q1 		– Sell
-65,900
Closed -$79K – 6758
2016
Q4 		$79K Sell
65,900
-10,100
-13% -$69.5K ﹤0.01% 2115
2016
Q3 		$44K Buy
76,000
+8,700
+13% +$73.6K ﹤0.01% 2583
2016
Q2 		$38K Buy
+67,300
New +$423K ﹤0.01% 2647

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cutler Group's IOVA Position: Q1 2024 in Review

Cutler Group opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2024: 2,397 shares worth $35K. The stake represents 0.01% of the portfolio and ranks #807 among its holdings. This is a return to the name: Cutler Group previously reported a position in IOVA as recently as Q3 2023.

Cutler Group first reported a position in IOVA in Q4 2015 and has held it in 23 quarters since. The position peaked at $1M in Q3 2021. 273 funds tracked by Wall St. Rank hold IOVA as of Q1 2024.

  • Cutler Group held 2,397 shares of Iovance Biotherapeutics worth $35K as of Q1 2024.
  • Iovance Biotherapeutics was a new Cutler Group position in Q1 2024.
  • Iovance Biotherapeutics made up 0.01% of Cutler Group's portfolio in Q1 2024, its #807 holding.
  • Cutler Group first reported a position in Iovance Biotherapeutics in Q4 2015 and has held it in 23 quarters since.
  • Cutler Group's Iovance Biotherapeutics position peaked at $1M in Q3 2021.
  • 273 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.